Vevey, Switzerland (ots/PRNewswire) - Focusing on an increased sourcing of high-quality coffee, as well as implementing regenerative practices, gender equality programs and projects to increase access to healthcare and clean water. Nespresso aims to continue to support the local community and economy by investing 20 ...
Bern, Switzerland (ots/PRNewswire) - - Its proprietary innovative polymer technology reduces bacterial bioburden without triggering antimicrobial resistance, one of the top global public health threats - The Advanced Wound Dressing (AWD) market is valued at 4.5 billion USD and is witnessing increasing demand and ...
Zug, Switzerland (ots) - SHL Medical, a world-leading solutions provider of advanced drug delivery systems and SteriPack Group, renowned global supplier of secondary packing and final assembly services to the pharmaceutical industry, enter a non-exclusive strategic partnership. Together, they aim to establish a pre-validated final assembly service at the SteriPack ...
Davos, Switzerland (ots/PRNewswire) - Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced that it has been recognized as the Top 3 IT services brand globally and the fastest growing IT services brand over a 5 year period, according to ...
Zug, Switzerland (ots/PRNewswire) - - Libtayo (cemiplimab) is a leading PD-1 inhibitor that has shown efficacy in the treatment of certain patients with cutaneous squamous cell carcinoma, advanced basal cell carcinoma, advanced non-small cell lung cancer and advanced cervical cancer, and is approved by regulatory ...
Zug, Switzerland and Paris (ots/PRNewswire) - Bylvay (odevixibat) is the first and only oral treatment available in Canada for the treatment of pruritus due to this rare genetic condition Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical company focused on transformative medicines in oncology, ...
Silony Medical International AG
Frauenfeld, Switzerland (ots/PRNewswire) - The transaction includes all cervical and lumbar fusion products, including the STALIF® technology platform Silony Medical International AG (the company), a growing challenger to "big medtech" in the global spinal fusion market, has signed a definitive agreement to acquire Centinel Spine's Global Fusion Business. This combines Silony's Verticale® posterior screw & rod fusion ...
CRANS-MONTANA, Switzerland (ots/PRNewswire) - Sports science & wellbeing education company, MAVERICKS Life Co., announces the release of its new Holistic Training Syllabus, rooted in evolutionary biology and epigenetics theory. It's a brand new innovation in the sports and fitness sector. Recent scientific studies* have led to groundbreaking development that is ...
Zug, Switzerland (ots/PRNewswire) - Capri Sun Group Holding AG, the no. 1 kids drink brand in the world, has announced today that it will take back the sales and distribution of its iconic pouch drinks in France, Monaco, Great Britain, Netherlands, Belgium, Luxemburg, Sweden, Spain, and Portugal in 2024, bringing to ...
Zug, Switzerland (ots/PRNewswire) - Klarpay AG, a leading global payments solution provider, is delighted to announce its partnership with Janut Angehrn and Julie Herzig, part of the Swiss Youth Olympic Sailing talent pool, as their official sponsor. This sponsorship is a testament to Klarpay's commitment to corporate social responsibility. As a proud Swiss company, Klarpay AG recognises the potential and dedication ...
Lausanne, Switzerland (ots) - - Debiopharm will highlight diversified approaches and commitment to improving outcomes for patients with cancer at the 2023 American Society of Clinical Oncology Conference - A poster presentation and discussion will cover promising interim results with Debio 0123, a potent, highly ...
Lausanne, Switzerland (ots) - - Debiopharm combines its potent WEE1-inhibitor Debio 0123 with standard-of-care therapy to short-circuit DNA damage repair (DDR) in adults with recurrent or progressive small cell lung cancer (SCLC). - The first patient dosed at Vall d’Hebron Hospital (Barcelona, Spain), was ...
Basel, Switzerland (ots) - Pioneer in advancing tomorrow’s standard of care to cure cancer and infectious diseases, Debiopharm selects Genedata Profiler, an industry-leading digital platform for translational and reverse translational research, as the cornerstone of its research and development strategy. Genedata, the leading provider of enterprise software solutions ...
Lausanne, Switzerland (ots/PRNewswire) - - Debiopharm is developing personalized radiotherapy through a theranostic approach, combining diagnostic imaging (Debio 0328 a gallium-labelled imaging tool) and therapeutic components (Debio 0228, a lutetium-labelled radioligand), thus allowing the pre-identification and ...
Lausanne, Switzerland (ots) - - Debiopharm is developing personalized radiotherapy through a theranostic approach, combining diagnostic imaging (Debio 0328 a gallium-labelled imaging tool) and therapeutic components (Debio 0228, a lutetium-labelled radioligand), thus allowing the pre-identification and treatment of ...
Medison Pharma; Alnylam Pharmaceuticals
Zug, Switzerland (ots/PRNewswire) - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies for patients in international markets, have announced an expansion of their ...
Paris, France and Lausanne Switzerland (ots) - ● The round is co-led by M Ventures and Debiopharm Innovation Fund with Omnes Capital; all joining as new investors ● Series A will enable Iktos to expand its AI technology platform and launch Iktos Robotics; an AI-driven automated end-to-end drug discovery service ...
Lausanne, Switzerland (ots) - Debiopharm obtains global rights from Novo Nordisk for the development of their ubiquitin-specific protease 1 (USP1) inhibitor Debiopharm (www.debiopharm.com), an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow’s standard-of-care treatments to cure cancer and infectious diseases, today announced having ...
Kaiseraugst, Switzerland, Heerlen, Netherlands and Geneva (ots/PRNewswire) - This is a joint press release by Koninklijke DSM N.V. (DSM), Firmenich International SA (Firmenich) and Danube AG, to be renamed DSM-Firmenich AG (the Company) in connection with the voluntary public exchange offer by the Company for all the issued and outstanding ordinary shares in the share ...
Glion Institute of Higher Education
Montreux, Switzerland and PARIS-LA Defense (ots/PRNewswire) - Glion Institute of Higher Education, a benchmark business school specializing in hospitality and luxury professions; and ESSEC Business School, a leading management institution, are joining forces to offer a Global Executive Master's degree in Hospitality ...
Cham, Switzerland (ots/PRNewswire) - Etrel, a Landis+Gyr company, and ON Power, an Icelandic electricity supplier and charging service provider, cooperate on scaling the company's EV charging service offering in Iceland with the help of the charge point management system OCEAN. ON Power, a charging service provider ...
Kaiseraugst, Switzerland, Heerlen, Netherlands and Geneva (ots/PRNewswire) - THIS PRESS RELEASE IS NOT FOR GENERAL RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO, DIRECTLY OR INDIRECTLY, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR REGULATIONS This is a joint press ...
Davos, Switzerland (ots/PRNewswire) - Infosys brand value grows to US$13 billion according to Brand Finance Global 500 2023 Report Infosys (NSE, BSE, NYSE: INFY), a global leader in next-generation digital services and consulting, today announced that it has been recognized as the top 3 most valuable IT services ...
Lausanne, Switzerland (ots/PRNewswire) - - Acromegaly and gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare diseases that require life-long chronic treatment. Monthly somatostatin analog (SSA) injections are the standard of care as first-line medical treatment. - Debiopharm is developing Debio 4126, a ...